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The genes encoding the catalytic (pyrB) and regulatory (pyr!) polypeptides of aspartate transcarbamoylase
(ATCase, EC 2.1.3.2) from several members of the family Enterobacteriaceae appear to be organized as
bicistronic operons. The pyrBI gene regions from several enteric sources were cloned into selected plasmid
vectors and expressed in Escherichia coli. Subsequently, the catalytic cistrons were subcloned and expressed
independently from the regulatory cistrons from several of these sources. The regulatory cistron of E. coli was
cloned separately and expressed from lac promoter-operator vectors. By utilizing plasmids from different
incompatibility groups, it was possible to express catalytic and regulatory cistrons from different bacterial
sources in the same cell. In all cases examined, the regulatory and catalytic polypeptides spontaneously
assembled to form stable functional hybrid holoenzymes. This hybrid enzyme formation indicates that the r:c
domains of interaction, as well as the dodecameric architecture, are conserved within the Enterobacteriaceae.
The catalytic subunits of the hybrid ATCases originated from native enzymes possessing varied responses to
allosteric effectors (CTP inhibition, CTP activation, or very slight responses; and ATP activation or no ATP
response). However, each of the hybrid ATCases formed with regulatory subunits from E. coli demonstrated
ATP activation and CTP inhibition, which suggests that the allosteric control characteristics are determined by
the regulatory subunits.
Aspartate transcarbamoylase (carbamoylphosphate:L-
aspartate carbamoyl-transferase; EC 2.1.3.2. [ATCase])
catalyzes the first unique step of pyrimidine biosynthesis in
Escherichia coli. The enzyme from E. coli is the most
studied representative of the class B ATCase enzymes (3,
14, 29, 39). It is a dodecamer with a molecular weight of
310,000 composed of six identical catalytic polypeptides
organized as enzymatically functional catalytic trimers (C3)
and six identical regulatory polypeptides organized as regu-
latory dimers (r2) (17, 37). These subunits are associated as
a zinc-dependent 2(c3):3(r2) holoenzyme possessing a variety
of intricate protein-protein interactions (9, 17, 32, 33, 37)
which determine heterotropic allosteric effects and homo-
tropic substrate characteristics (4, 8, 19, 22, 25). ATCase
from E. coli is allosterically inhibited by CTP and activated
by ATP. The holoenzyme exhibits cooperative homotropic
interactions in response to the substrates aspartate (16) and
carbamoyl phosphate (4). The dodecamer can be reversibly
dissociated into its constituent subunits (C3 and r2) by treat-
ment with mercurials such as p-chloromercuribenzoate or
neohydrin (15, 41). The catalytic trimer possesses catalytic
activity but has no regulatory properties (17). The regulatory
dimer has no catalytic activity but binds the nucleotide
effectors CTP and ATP with stoichiometries consistent with
those of the holoenzyme (37). In the presence of zinc acetate
and dithiothreitol, these two subunits can be reassociated in
vitro to form a holoenzyme that is identical to the native
holoenzyme in allosteric, physical, and catalytic character-
istics (15).
In E. coli, adjacent cistrons encode the two polypeptide
chains of ATCase and are expressed in the order: promoter,
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leader, catalytic polypeptide, regulatory polypeptide (20, 30,
34, 36). The pyrB cistron codes for the catalytic polypeptide,
and pyrI codes for the regulatory polypeptide (34, 40). The
two cistrons are organized as a bicistronic operon possessing
a common control region characterized by a leader polypep-
tide and a UTP-dependent attenuator (27, 31, 36). When
pyrB and pyrI are expressed from transcriptionally indepen-
dent cistrons in the same cell, all detectable catalytic
polypeptides are incorporated into a functional ATCase
holoenzyme (13).
The regulatory characteristics of ATCases from various
members of the family Enterobacteriaceae have been com-
pared previously (3, 14, 23, 28, 38, 39). All of the enzymes
appeared to be class B ATCases as determined by molecular
weight (300,000), sigmoidal saturation by aspartate, and
dissociation into a smaller catalytic form (approximately
100,000) (14, 39). Despite the apparent structural similarities,
these enzymes differ from that of E. coli in homotropic
kinetic properties and in heterotropic effector responses
(Table 1). For example, ATP and CTP are both positive
effectors of the ATCases from Proteus vulgaris, Serratia
marcescens and Aeromonas hydrophila, while some
Yersinia strains are not effected by either nucleotide (14, 39).
Erwinia herbicola and Erwinia carnegieana are not affected
by ATP and are only minimally inhibited by CTP. Aspartate
concentrations required for half-maximal velocity range
from 3 mM for E. herbicola to 30 mM for P. vulgaris. The
divergent catalytic and regulatory characteristics appear to
be conserved within the general tribal classifications of the
Enterobacteriaceae (39).
In this paper we report the formation of hybrid ATCases
created by the in vivo assembly of native catalytic and
regulatory subunits from divergent bacterial sources. These
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286 FOLTERMANN ET AL.
TABLE 1. Characteristics of ATCases from selected members of
the Enterobacteriaceaea
Tribal
Enterobacteriaceae classifi- ATCase characteristics
cation
Citrobacter diversus Tribe I ATP activation
Citrobacterfreundii CTP inhibition
Edwardsiella tarda [S10.5 aspartate = 5-8 mM
Enterobacter aerogenes
Escherichia coli
Salmonella typhimurium
Shigella flexneri
Aeromonas hydrophila Tribe II ATP activation
Enterobacter liquefaciens CTP activation
Serratia marcescens [S]0.S aspartate = 17-20 mM
Proteus vulgaris Tribe III ATP activation
CTP activation
[S]o.5 aspartate = 30-35 mM
Yersinia enterocolitica Tribe IV No ATP effect
Yersinia kristensenii No CTP effect
Yersinia frederiksenii [S]0.5 aspartate = 4 mMb
Yersinia enterocolitica Activation by ATP and CTP
(different DNA [S ]o.s undetermined
relatedness group)c
Yersinia intermedia ATP activation
CTP and UTP inhibition
[S]o.5 undetermined
Erwinia carnegieana Tribe V No ATP effect
Erwinia herbicola CTP slight inhibition
[S]0.5 aspartate = 3 mM
a Summarized from Foltermann et al. (14), Wild et al. (38), Wild et al. (39),
and unpublished observations.
b [SJ0.5 determined for Y. enterocolitica.
c Various Y. enterocolitica strains showed different enzymatic characteris-
tics and corresponded to different DNA relatedness groups (14).
hybrid enzymes were evaluated for catalytic characteristics
and regulatory control.
MATERIALS AND METHODS
Bacterial strains. Bacterial strains used as sources ofDNA
for cloning pyrBI from various enteric bacteria are listed in
Table 2. The host strain for all plasmid constructions was E.
coli HB101-4442 (13) created by the insertion and subse-
quent excision of Mu cts into E. coli HB101 (5). A pyrBI
auxotroph of JM103 (24) was used as the host system when
pyrI was expressed on M13mp8. This strain was made
pyrBI- by P1 phage transduction with a lysate grown on a
heat-stable (43°C) Apr pyrBI strain generated by Mu d(lac
Apt) insertion (7).
Plasmid and bacteriophage vectors. Expression vectors (5,
7, 10, 21, 24), recombinant DNA plasmids, and bacterioph-
age (24) used in these experiments are described in Table 3.
Media. Bacteria were routinely grown on tryptone-yeast
extract (TYE) medium. Cultures used for ATCase assays
were grown in the modified M56 medium as described earlier
(39). Cultures used for large-scale plasmid preparations were
grown in M9 medium (24) supplemented with 0.2% glucose,
0.1% Casamino Acids (Difco Laboratories, Detroit, Mich.),
2 jig of thiamine per ml, and 30 ,ug of uracil per ml (as
required). Selective platings were performed on TYE plates
and on minimal plates supplemented as above containing the
appropriate antibiotics in the following concentrations: 40 ,ug
of ampicillin per ml, 25 ,ug of chloramphenicol per ml, and 25
,ug of tetracycline per ml.
Bacterial DNA isolation. Total genomic DNA from the
various enteric bacteria (except E. coli) was isolated by
pronase-sodium dodecyl sulfate treatment (2). The isolates
were subjected to purification by a standard CsCl density
ultracentrifugation technique (24) or were extracted four
times with an equal volume of buffer-saturated phenol fol-
lowed by two extractions with chloroform-isoamyl alcohol
(24:1, vol/vol) and dialyzed against several changes of DNA
buffer (10 mM Tris, 1 mM EDTA, pH 8).
F'-plasmid DNA was purified from E. coli K-12
(KLF17/KL132) carrying F'117 (F' pyrB+ argI+; E. coli
Genetic Stock Center no. 4255) by the procedures of Deonier
and Mirels (12);
Plasmid DNA isolation. Plasmid DNA was isolated as
previously described (31) by using a cleared lysate method.
Restriction and ligation. Restriction endonucleases and T4
DNA ligase were purchased from Bethesda Research Labo-
ratories, Inc. (Gaithersburg, Md.) and used as recommended
by the manufacturer. Ligation mixtures were ifncibated
overnight at 4°C. T4 DNA polymerase and Bal 31 were
obtained from Bethesda Research Laboratories and were
used by the adapted methods of Maniatis et al. (24).
Transformations. Competent cells of E. coli HB101-4442
were prepared and used by the procedures of Dagert and
Ehrlich (11) in the initial cloning of the pyrBI regions.
Isolates from the TYE-antibiotic plates were screened to
estimate the frequency of insertion, and all pyrBI transform-
ants were isolated from the minimal plates containing anti-
biotics. After the initial cloning, frozen competent cells were
used for transformation with plasmid DNA by the method of
Morrison (26).
Plasmid screening. Plasmids containing inserts were iden-
tified by the rapid plasmid isolation procedure of Barnes (1)
for quick screening application and by the Holmes and
Quigley technique (18) when restriction digests or transfor-
mations were to be performed with the DNA.
ATCase characterization. Cell extracts were prepared by
sonication, ATCase was assayed, and molecular weights
were determined by ascending Sephadex G-200 chromatog-
raphy as described previously (39). The assay was per-
formed at 28°C in the presence of 5 mM aspartate and 4 mM
carbamoyl phosphate except when noted differently. The
concentration of the nucleotide effectors, ATP and CTP, was
2 mM.
Activity stain. Nondenaturing 6% polyacrylamide slab gels
were used to analyze the subunit structure of ATCase. These
TABLE 2. Bacterial strains
Enterobacteriacae Description Source
Aeromonas hydrophila ATCC 7966 ATCCa
Edwardsiella tarda ATCC 15947 ATCC
Erwinia herbicola TAMU 177b B. G. Fosterb
Escherichia coli K-12, ECGSC 4255c B. J. Bachmannc
Proteus vulgaris ATCC 13315 ATCC
Salmonella typhimurium LT-2, SGSCd K. E. Sandersond
Serratia marcescens HY, ATCC 8195 W. L. Belsere
a Strains originated from American Type Culture Collection.
b Texas A&M University.
c E. coli Genetic Stock Center (Yale University).
d Salmonella Genetic Stock Center (University of Calgary).
e University of California, Riverside.
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gels were specifically stained for ATCase activity by precip-
itating the enzymatically released Pi as an insoluble lead salt,
followed by conversion to lead sulfide (M. A. Bothwell,
Ph.D. thesis, University of California, Berkeley, 1975).
Histidine was used instead of imidazole to avoid nonspecific
staining and background problems encountered when using
aged imidazole and crude cell extracts. Since enteric
ATCases have been shown to vary in substrate require-
ments, the reaction mix for the gel system contained high
levels of aspartate (100 to 150 mM), 1 to 2 mM ATP, and 3.5
mM carbamoyl phosphate. The reaction was allowed to
proceed for 15 min at room temperature with substrate
present.
Samples for activity gels were prepared by sonication as
described above for the enzymatic assay or by the following
1 2 3 4 5 6 7 a 9 10
S
I 12 13 14 15
aa
TABLE 3. Plasmids, bacteriophage, and recombinant molecules
SzdPlasmida Markerb Enzymec ) ATP CTPe(kb)
pPBhl0l-Ah ApT pyrBI BamHI 11 + +
pPBh4Ol-Et ApT pyrBI BamHI 17 +
pPBhi03-Eh Tcr pyrBI PstI(pY 11 0 s-
pPBcllO-Eh Tcr pyrB PstI 10 0 0
pPBhlO4-Ec Tcr pyrBI PstI 10.4 + -
pPBc2Ol-Ec Tcr pyrB BglIlg 9.7 0 0
pPBhlO3-Pv Apr pyrBI HindIII-NruIh 11.5 + +
pPBc4Ol-Pv Apr pyrB Sstl' 6.5 0 0
pPBh101-St Apr Tcr EcoRI-AvaI 7.1 + -
pyrBI
pPBc1Ol-St TcT pyrB PstI >20 0 0
pPBh1Ol-Sm Apr pyrBI HindIII >20 + +
pPBclOl-Sm Tcr pyrB PstI 5.0 0 0
pPBr3Ol-Ec Cmr pyrI Pstl-HindIIIk 6.8 No catalysis
M13-PI5101-Ec pyrl AvaIll 8.0 No catalysis
pACYC184 Tcr Cmr 3.9 Cloning vector
pBH20 Apr Tcr 4.5 Cloning vector
pBR322 Apr Tcr 4.3 Cloning vector
pUC8 Apr 2.7 Cloning vector
M13mp8 None 7.3 Phage.
Plasmid nomenclature is defined for a series of plasmids constructed to
contain specific cistrons from the pyrBI operon. All are designated pPB
(plasmid containing the pyrB operon). The polypeptides produced from the
construction are identified as holoenzyme (h, both catalytic and regulatory
chains produced), catalytic subunit (c, produces catalytic chain only), and
regulatory subunit (r, produces regulatory chain only). If the cloned cistrons
are carried by a pBR322 origin vector, the plasmids are designated by 100 or
200 series numbers. If the cloned cistrons are carried by a P1SA vector (e.g.,
pACYC184), the plasmids are designated as 300 series. Recombinant plasmids
involving pUC series plasmids are 400 series, and phage borne fragments are
designated as 500 series. The bacterial origins of the cloned cistrons are
designated by the generic description, such that Ah indicates A. hydrophila;
Et, E. tarda; Ec, E. coli; Eh, E. herbicola; Pv, P. vulgaris; St, S. typhimu-
rium; and Sm, S. marcescens.
b Antibiotic resistance markers and expressed pyrBI genes only.
c Primary restriction endonuclease used in cloning procedures.d Size of cloned fragment plus plasmid vector.
e Allosteric effector response to 2 mM ATP or CTP (+, activation; -,
inhibition; s-, slight inhibition; 0, no effect).
f PstI(p) indicates partial restriction cleavage.
' An internal deletion of approximately 0.7 kilobases of pPBhlO4-Ec.
h The preliminary fragment was produced by partial HindIII digestion, and
the subclone resulted from an internal NruI deletion.
The preliminary fragment was produced by SstI digestion; however, Bal 31
was used to reduce the fragment size before use of these studies. The smaller
fragment was inserted into an SmaI site.
J pPBhlO1-St was obtained from Rod Kelln, University of Regina (pGM1).
The subcloned fragment was isolated from pPBr101-Ec (13) by double
restriction and inserted into the cloning vector by blunt-end ligation into a
BamHI site.
cThe restriction fragment from pPHhlO4-Ec was inserted into a HincII site.
FIG. 1. ATCase activity gel for detection of hybrid enzyme
formation. The holoenzyme migrates much more slowly through the
native 6% acrylamide gel and is represented by higher bands. The
catalytically active trimers (C3) migrate more rapidly and can be
detected in lanes 5, 8, 11, 14, and 15. The lanes contain extracts from
the following genetic constructions: 1, E. coli HB101-4442, a pyrBIU
derivative of HB101; 2, E. coli K-12, chromosomal pyrBI; 3, E. coli
holoenzyme expressed from pPBhlO4-Ec; 4, E. coli "hybrid"
holoenzyme produced from pPBc2Ol-Ec and pPBr3Ol-Ec; 5, E. coli
catalytic subunit produced from pPBc2Ol-Ec; 6, E. coli regulatory
subunit from pPBr3Ol-Ec; 7, P. vulgaris-E. coli hybrid holoenzyme
produced from pPBc4Ol-Pv and pPBr3Ol-Ec; 8, P. vulgaris catalytic
subunit from pPBc4Ol-Pv; 9, P. vulgaris holoenzyme from
pPBhlO3-Pv; 10, E. herbicola-E. coli hybrid holoenzyme produced
from pPBcllO-Eh and pPBr3Ol-Ec; 11, E. herbicola catalytic
subunit from pPBcllO-Eh; 12, E. herbicola holoenzyme from
pPBhlO3-Eh; 13, S. marcescens-E. coli hybrid holoenzyme pro-
duced from pPBclOl-Sm and pPBr3Ol-Ec; 14, S. marcescens cata-
lytic subunit from pPBclOl-Sm; and 15, S. marcescens holoenzyme
from pPBhlO1-Sm.
procedure for screening a large number of transformants.
Single-colony isolates were inoculated into 5 ml of TYE
containing the appropriate antibiotic and incubated in a tube
roller overnight at 37°C. This culture was harvested by
centrifugation, washed once in 40 mM potassium phosphate
buffer (pH 7.0), and resuspended in 200 to 300 ,ul of the same
buffer containing 0.02 mM zinc acetate and 1 mM dithiothrei-
tol. Samples were subjected to sonication in disposable
plastic transfer pipettes with a cup horn sonicator (intensity
6 for five 30-s pulses). Cell extracts were prepared by
centrifugation in a microcentrifuge for 5 min at 80C. Super-
natants were decanted, and 20 to 30 FLl was run on an activity
gel.
RESULTS
Characterization of native ATCases from plasmids carrying
pyrBi cistrons. The pyrBl cistrons were cloned from prepa-
rations of total chromosomal DNA from each enteric source
except E. coli (cloned from F' DNA [13]). The ATCase
produced from each cloned fragment was compared with the
enzyme already described from the parental source (Tables 1
and 3). The subunit architecture of each enzyme was deter-
mined by native activity gel and molecular sieve chromatog-
raphy (Sephadex G-200). In all cases, the intact pyrBI
operons were cloned from the chromosomal preparation,
and the expressed ATCase holoenzymes were observed to
be stable (Fig. 1) (unpublished observation). Table 3 sum-
marizes the following characteristics of the plasmids carry-
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288 FOLTERMANN ET AL.
TABLE 4. Effector response of hybrid ATCases
Effector responseb at
ATCase [S]0.5 Asp [Aspartate]
holoenzymea, (mM)c
2 mM ATP 2 mM CTP
Native
pPBhlO4-Ec + (140) - (25) 5
pPBhlO3-Pv + (210) + (130) 30
pPBhlO3-Eh 0 (100) s- (75) 3
pPBhl0l-Sm + (150) + (135) 20
Hybrid
pPBc201-Ec
pP13r301-Ec + (120) - (20) 5
pPBc40l-Pv
pPBr301-Ec + ( 10)d - (25) 4
pPBcllO-Eh
pPBr301-Ec + ( 10)d - (50) 4
pPBclOl-Sm
pPBr301-Ec + (170) - (25) 125
a Plasmid characterization described in Table 3. The bacterial species from
which the recombinant plasmids were formed is indicated by the alphabetical
descriptor: Ec, E. coli; Pv, P. vulgaris; Eh, E. herbicola; Sm, S. marcescens.
Basic nomenclature: pPBh, plasmid, pyrB operon holoenzyme; pPBc, plasmid
pyrB operon, catalytic chain production only; pPBr, plasmid pyrB operon,
regulatory chain production only.
b Percent activity of ATCase determined under standard conditions in the
absence of nucleotide allosteric ligands (+, activation; -, inhibition; s-,
slight inhibition).
c Aspartate concentrations approximating [S]0.5 for each of the
holoenzymes. These concentrations were used to determine allosteric re-
sponse.
d Activation is more pronounced at lower aspartate concentrations (e.g.,
130% at 2 mM).
ing pyrBI regions from various enteric bacteria: the enzyme
used to clone the cistrons, the size of the plasmid, and the
nature of the responses of the enzymes to ATP and CTP. In
all cases, these responses are the same as those determined
for enzyme preparations from the native bacterial sources
(data not shown).
Determination of subunit architecture of native and hybrid
enzymes. Figure 1 shows the subunit architecture of
ATCases produced from selected native pyrBI and pyrB
plasmids and hybrid constructions. Separate catalytic trim-
ers were observed to move readily through the native
acrylamide gel, while holoenzymes migrated at a much
slower rate. St4ble holoenzyme was detected in each com-
bination of separately expressed catalytic and regulatory
cistrons from different enteric bacteria. Virtually all the
catalytic activity was recovered in an aggregated structure,
and no catalytic trirrpr activity was noted. These gels
measure differences owing to both protein charge' and mo-
lecular size and permit the identification of various molecu-
lar conformations of active enzyme. On occasion, discrete
bands might be observed immediately below that of the
holoenzyme (Fig. 1, lanes 2 and 3). These enzymes appear to
comigrate with the regulatory-deficient species of ATCase,
2(c3):2(r2) (6, 33). Specific mobility differences were ob-
served for the catalytic subunits of P. vulgaris and E.
herbicola as compared with the E. coli catalytic subunit.
Characterization of hybrid ATCase holoenzymes. Table 4
summarizes the allosteric responses of the'hybrid holo-
enzymes. In each case, the hybrid holoenzymes possess a
regulatory response (CTP inhibition, ATP activation) char-
acteristic of the E. coli holoenzyme, independent of the
source of the catalytic subunit. In addition, most of the
enzymes possessed an [S]0.5 of 4 to 5 mM aspartate; the only
exception was the S. marcescens-E. coli hybrid which
required 125 mM aspartate for half-maximal saturation. The
unusually high requirement of this hybrid for aspartate is
identical to that reported for the enzyme assembled from
purified subunits (35).
Characterization of hybrid ATCase formed from phage
carrying the pyrI cistron. All hybrids produced with the pyrI
gene product expressed from the lac promoter-operator of
the M13 system also seemed to be stable and showed the
same kinetic and effector responses as hybrids generated
with plasmid-expressed pyrI gene product.
DISCUSSION
Previous studies have demonstrated that the genes ex-
pressing ATCase from E. coli are organized as a bicistronic
operon (20, 30, 36). The pyrBI operon organization has been
conserved among several additional members of the Entero-
bacteriaceae including Salmonella typhimurium, S. marces-
cens, P. vulgaris, and E. herbicola. Unpublished DNA
sequencing studies in this laboratory (S. marcescens, P.
vulgaris, and E. herbicola) and elsewhere (S. typhimurium;
R. Kelln, University of Regina, Regina, Saskatchewan,
Canada) have verified a similar bicistronic organization for
several of the cloned genetic systems described in this study.
The native holoenzymes produced from these cloned enteric
operons appear identical to those observed from the native
bacterial sources (14, 39) as shown by molecular weight
determination and by enzymatic characteristics.
It has been shown that stable ATCase holoenzyme is
formed in vivo when E. coli pyrB and pyrI cistrons are
expressed separately from plasmids of different incom-
patibility groups simultaneously present in the cell (13). This
technique was used to construct hybrid holoenzymes in
vivo, utilizing the native subunits from various members of
the Enterobacteriaceae. Figure 1 reveals that, in each case,
stable hybrid holoenzymes were formed with catalytic
subunits from one bacterium and regulatory subunits from E.
coli. Earlier studies have suggested that ATCase holo-
enzymes from various members of the Enterobacteriaceae
have the same molecular architecture because they have a
similar molecular weight (300,000 + 15,000), sigmoidal
aspartate saturation curves, and the ability to dissociate into
functional catalytic subunits (100,000 molecular weight) (14,
39). The ability to form in vivo hybrid holoenzymes among
various members of the Enterobacteriaceae confirms that
there is a common overall architectural structure among the
ATCases.
Each catalytic site is formed at the interface of two
monomers of a catalytic trimer (19, 22), and it has been
proposed that each participates in a complex communication
network with a catalytic site in the other trimer through
several domains of bonding (c: :r:r: :c) (8, 9). The assembly of
the holoenzyme, 2(c3):3(r2), provides six c:c bonding do-
mains within the catalytic trimers, three r:r bonding domains
within the regulatory dimers, and six r:c domains linking the
regulatory and catalytic subunits. Furthermore, there may
be some additional contact between the catalytic chains in
separate trimers despite a large aqueous center in the
holoenzyme (19, 22, 25). In hybrid holoenzyme formation,
r:c domains linking the regulatory and catalytic subunits are
stably formed and define heterologous protein-protein inter-
faces which establish functional allosteric control and com-
munication between active sites. All these hybrid holo-
enzymes exhibited a substrate requirement of 4 to 5 mM
J. BACTERIOL.
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HYBRID ASPARTATE TRANSCARBAMOYLASES 289
aspartate, except for the S. marcescens c3-E. coli r2 hybrid.
The unusually high substrate requirement of 125 mM
aspartate for this hybrid is consistent with the earlier in vitro
work of Shanley et al. (35) and appears to be correlated with
differences in the amino acid sequence of the Serratia
catalytic chain (K. M. Kedzie and J. R. Wild, unpublished
observation). The same communication network that signals
a homotropic response to substrate binding may also provide
a means by which heterotropic effector- response is relayed
between subunits. Hybrid holoenzymes constructed with the
various enteric catalytic subunits and E. coli regulatory
subunits possessed an effector response that is characteristic
of the E. coli ATCase. These heterotropic responses are
often vastly different from the native effector response
(Table 4) and suggest that the regulatory subunit directly
imposes its allosteric control over various catalytic subunits.
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